Vident Advisory’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.21M Buy
17,032
+4,471
+36% +$353K 0.01% 791
2025
Q4
$1.03M Sell
12,561
-451
-3% -$35.1K 0.01% 790
2025
Q3
$977K Buy
13,012
+2,279
+21% +$170K 0.01% 839
2025
Q2
$795K Buy
10,733
+1,522
+17% +$106K 0.01% 828
2025
Q1
$743K Buy
9,211
+3,318
+56% +$285K 0.01% 840
2024
Q4
$461K Buy
5,893
+738
+14% +$62.7K 0.01% 996
2024
Q3
$484K Sell
5,155
-1,056
-17% -$88.6K 0.01% 937
2024
Q2
$484K Sell
6,211
-407
-6% -$33.2K 0.01% 901
2024
Q1
$602K Buy
6,618
+324
+5% +$27K 0.01% 749
2023
Q4
$487K Buy
6,294
+203
+3% +$14.2K 0.01% 786
2023
Q3
$414K Buy
+6,091
New +$443K 0.01% 767

Other funds holding GEHC

Vident Advisory's GEHC Position: Q1 2026 in Review

Vident Advisory increased its GE HealthCare (GEHC) stake by 36% in Q1 2026, buying an estimated $353K and bringing the position to 17,032 shares worth $1.21M. The position accounts for 0.01% of the portfolio, ranked #791.

Vident Advisory first reported a position in GEHC in Q3 2023 and has held it in 11 quarters since. 1,263 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

  • Vident Advisory held 17,032 shares of GE HealthCare worth $1.21M as of Q1 2026.
  • Vident Advisory bought 4,471 GE HealthCare shares in Q1 2026, an estimated $353K.
  • GE HealthCare made up 0.01% of Vident Advisory's portfolio in Q1 2026, its #791 holding.
  • Vident Advisory first reported a position in GE HealthCare in Q3 2023 and has held it in 11 quarters since.
  • 1,263 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Vident Advisory's 13F filing for Q1 2026, filed 15 May 2026.